Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Case Report
  • Published:

Allogeneic bone marrow transplantation restores IGF-I production and linear growth in a γ-SCID patient with abnormal growth hormone receptor signaling

Summary:

Severe combined immunodeficiency (SCID) is a heterogeneous group of disorders characterized by a severe defect of both T- and B-cell immunity, which generally require allogeneic bone marrow transplantation (BMT) within the first years of life. We previously reported a patient affected with an X-linked SCID due to L183S hemizygous missense γ chain mutation, whose severe short stature was due to a peripheral growth hormone (GH) hyporesponsiveness associated to abnormal GH receptor (GH-R) signal transduction. In this study, we report the effect of BMT on the GH-R/insulin-like growth factor I (IGF-I) axis. After BMT, the patient showed a significant improvement in linear growth and normalization of basal- and GH-stimulated IGF-I values, which paralleled a fully competent immunological reconstitution. This suggests that cells derived from the hematopoietic stem cell may exert an unexpectedly significant role in producing IGF-I. This may also suggest that stem cell-based therapies may be useful for the correction of non-hematopoietic inherited disorders, such as those of GH-R/IGF-I axis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Ursini MV, Gaetaniello L, Ambrosio R et al. Atypical X-linked SCID phenotype associated to growth hormone hyporesponsiveness. Clin Exp Immunol 2002; 129: 502–509.

    Article  CAS  Google Scholar 

  2. Rosenfeld RG, Rosembloom AL, Guevara-Aguirre J . Growth hormone (GH) insensitivity due to primary GH receptor deficiency. Endocr Rev 1994; 15: 369–370.

    Article  CAS  Google Scholar 

  3. Freeth JS, Silva CM, Whatmore AJ, Clayton PE . Activation of the signal transducers and activators of transcription signaling pathway by growth hormone (GH) in skin fibroblasts from normal and GH binding protein-positive Laron syndrome children. Endocrinology 1998; 139: 20–28.

    Article  CAS  Google Scholar 

  4. Salerno M, Balestrieri B, Matrecano E et al. Abnormal GH receptor signaling in children with idiopathic short stature. J Clin Endocrinol Metab 2001; 86: 3882–3888.

    Article  CAS  Google Scholar 

  5. Han VK, D'Ercole AJ, Lund PK . Cellular localization of somatomedin (insulin-like growth factor) messenger RNA in the human fetus. Science 1987; 236: 193–197.

    Article  CAS  Google Scholar 

  6. Nyman T, Pekonen F . The expression of insulin-like growth factors and their binding proteins in normal human lymphocytes. Acta Endocrinol 1993; 128: 168–172.

    Article  CAS  Google Scholar 

  7. Le Roith D, Bondy C, Yakar S et al. The somatomedin hypothesis: 2001. Endocr Rev 2001; 22: 53–74.

    Article  CAS  Google Scholar 

  8. Brauner R, Adan L, Souberbielle JC et al. Contribution of growth hormone deficiency to the growth failure that follows bone marrow transplantation. J Pediatr 1997; 130: 785–792.

    Article  CAS  Google Scholar 

  9. Sjogren K, Liu JL, Blad K et al. Liver-derived insulin-like growth factor-I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. Proc Natl Acad Sci USA 1999; 96: 7088–7092.

    Article  CAS  Google Scholar 

  10. Yakar S, Liu JL, Stannard B et al. Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci USA 1999; 96: 7324–7329.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported by a grant from MIUR Prin 2002, Rome, Italy, and from Regione Campania, legge 502.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C Pignata.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Salerno, M., Busiello, R., Esposito, V. et al. Allogeneic bone marrow transplantation restores IGF-I production and linear growth in a γ-SCID patient with abnormal growth hormone receptor signaling. Bone Marrow Transplant 33, 773–775 (2004). https://doi.org/10.1038/sj.bmt.1704421

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704421

Keywords

This article is cited by

Search

Quick links